Decision Making in a World of Comparative Effectiveness Research : A Practical Guide

"Acknowledgements" -- "Contents" -- "Contributors" -- "Part I: Introduction" -- "Chapter 1: Introducing Decision Making in a World of Comparative Effectiveness Research" -- "Reference" -- "Chapter 2: Perspectives of Comparative Effectiveness Research from the World of Decision Making" -- "2.1 Initial Thoughts on the Evolving Conception of CER" -- "2.2 A Survey of Key Themes Covered in this Book" -- "2.2.1 How Are Demands for Evidence of Comparative Effectiveness Changing? What Strategies Are Available to Manufacturers?" -- "2.2.2 How Have Methods for Conducting CER Changed? What Is the Emerging Picture?" -- "2.2.3 What Has Been the Impact of CER on Public Payers in the United States (US) Compared with Other National Health Systems? How Is this Changing?" -- "2.2.4 What Are Current Constraints or Barriers to the Use of CER, and How Could this Change?" -- "2.3 Closing Thoughts" -- "References" -- "Part II: The Future of Comparative Effectiveness Research for Evidence Developers: Perspectives from Pharmaceutical Decision Makers" -- "Chapter 3: Perspectives on the Use of Comparative Effectiveness Research by Life Sciences Executives: An Interview with Mike Bonney" -- "References" -- "Chapter 4: Perspectives on the Use of Comparative Effectiveness Research by Life Sciences Executives: An Interview with a Senior Executive at an International Life Science Company" -- "Reference" -- "Chapter 5: Comparative Effectiveness Research: A Pharmaceutical Industry Perspective on Outlook, Dilemmas, and Controversies" -- "5.1 Introduction" -- "5.2 What Is CER in the Pharmaceutical Context?" -- "5.3 What Are the Current Efforts Toward Using CER?" -- "5.4 What Are the Current Challenges and Barriers for CER Research?" -- "5.4.1 Challenges and Costs Associated with Designing the Study